Australia TGA ARTG record

Clinical chemistry toxicology/drug detection IVDs

Australia TGA ARTG Registered Device · Natraplas Pty Ltd · Hangzhou Alltest Biotech Co Ltd (China) · Class IIa · Started October 12, 2023

Good Name: Natraplas Pty Ltd - Clinical chemistry toxicology/drug detection IVDs

Device classification

Risk Class: Class IIa
Product Type: IVD
ARTG Category: IVD

Registration information

Start Date: October 12, 2023
Effective Date: November 06, 2023

Sponsor

Name: Natraplas Pty Ltd

Manufacturer

Name: Hangzhou Alltest Biotech Co Ltd (China)
Country: China
Address: 550# Yinhai Street Hangzhou Economic and Technological Development Area, Hangzhou, 310018

Intended purpose

IVDs intended to detect drugs and or drug metabolites in laboratory or point of care settings.

About this record

Access comprehensive regulatory information for Clinical chemistry toxicology/drug detection IVDs in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by Natraplas Pty Ltd, manufactured by Hangzhou Alltest Biotech Co Ltd (China) in China. The device registration started on October 12, 2023.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.